In this context, the tumour-associated CA IX could be considered a valid biomarker of the non-invasive liquid biopsy, which is viewed as a technique that offers future research on precision diagnosis and treatment of tumours in a non-invasive manner. The gene discussed is CA9; the disease is neoplasm.